Nevro Corp. Sustainability Profile
Nevro Corp., a leading medical device company headquartered in the United States, specialises in innovative solutions for chronic pain management. Founded in 2006, Nevro has made significant strides in the neuromodulation industry, particularly with its proprietary HF10 therapy, which offers a unique approach to spinal cord stimulation. With a strong presence in North America and expanding operations in Europe and Asia, Nevro is committed to improving patient outcomes through advanced technology. The company has garnered recognition for its clinical efficacy and safety, positioning itself as a frontrunner in the market. Nevro's dedication to research and development continues to drive its success, making it a pivotal player in the evolving landscape of pain management solutions.
DitchCarbon Score
How does Nevro Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nevro Corp.'s score of 25 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nevro Corp.'s reported carbon emissions
Nevro Corp., headquartered in the US, currently does not report any specific carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As a result, Nevro Corp. appears to be in the early stages of developing its climate strategy and emissions reporting. Without specific emissions data or reduction initiatives, it is unclear how the company plans to address its carbon footprint or contribute to broader climate goals. In the context of the medical technology industry, where sustainability is increasingly important, Nevro Corp. may need to consider implementing robust climate commitments and transparent emissions reporting to align with industry standards and stakeholder expectations.
How Carbon Intensive is Nevro Corp.'s Industry?
How Carbon Intensive is Nevro Corp.'s Location?
Nevro Corp.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Nevro Corp. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
